4JLH | HIV-1 Integrase Catalytic Core Domain A128T Mutant Complexed with Allosteric Inhibitor | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Feng, L., Kvaratskhelia, M. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.09 | ||||||||||||
ligand | 0L9, CAF, SO4 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors., Feng L, Sharma A, Slaughter A, Jena N, Koh Y, Shkriabai N, Larue RC, Patel PA, Mitsuya H, Kessl JJ, Engelman A, Fuchs JR, Kvaratskhelia M, J Biol Chem. 2013 Apr 24. PMID:23615903 |
Data retrieval |
View 4JLH in 3D |
Visual 3D analysis of 4JLH |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4JLH |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |